NO307686B1 - Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter - Google Patents

Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter

Info

Publication number
NO307686B1
NO307686B1 NO940008A NO940008A NO307686B1 NO 307686 B1 NO307686 B1 NO 307686B1 NO 940008 A NO940008 A NO 940008A NO 940008 A NO940008 A NO 940008A NO 307686 B1 NO307686 B1 NO 307686B1
Authority
NO
Norway
Prior art keywords
tablet
tablets
preparation
pharmaceutical tablet
colestipol hydrochloride
Prior art date
Application number
NO940008A
Other languages
English (en)
Norwegian (no)
Other versions
NO940008L (no
NO940008D0 (no
Inventor
Robert Wu-Wei Shen
Jeffrey Ellis Price
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO940008L publication Critical patent/NO940008L/no
Publication of NO940008D0 publication Critical patent/NO940008D0/no
Publication of NO307686B1 publication Critical patent/NO307686B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO940008A 1991-07-03 1994-01-03 Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter NO307686B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72504491A 1991-07-03 1991-07-03
PCT/US1992/005066 WO1993000915A1 (fr) 1991-07-03 1992-06-23 Comprimes a haute teneur en chlorhydrate de colestipol

Publications (3)

Publication Number Publication Date
NO940008L NO940008L (no) 1994-01-03
NO940008D0 NO940008D0 (no) 1994-01-03
NO307686B1 true NO307686B1 (no) 2000-05-15

Family

ID=24912923

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940008A NO307686B1 (no) 1991-07-03 1994-01-03 Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter

Country Status (18)

Country Link
US (1) US5490987A (fr)
EP (1) EP0592594B1 (fr)
JP (1) JP3313710B2 (fr)
KR (1) KR100240362B1 (fr)
AT (1) ATE173931T1 (fr)
AU (1) AU669664B2 (fr)
CA (1) CA2110166C (fr)
CZ (1) CZ286958B6 (fr)
DE (1) DE69227773T2 (fr)
DK (1) DK0592594T3 (fr)
ES (1) ES2124736T3 (fr)
FI (1) FI106843B (fr)
HU (1) HU222242B1 (fr)
NO (1) NO307686B1 (fr)
PL (1) PL169045B1 (fr)
RU (1) RU2108090C1 (fr)
SK (1) SK281920B6 (fr)
WO (1) WO1993000915A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129079C (fr) * 1993-08-03 2006-01-17 Tatsuo Nomura Hypocholesterolemiant pour administration par voie orale
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
ATE286386T1 (de) * 1999-10-19 2005-01-15 Genzyme Corp Direktkomprimierter tablettenkern auf polymerbasis
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
EP1699442A2 (fr) * 2003-12-31 2006-09-13 Genzyme Corporation Agents sequestrants des acides biliaires a base de polymeres d'amine aliphatique a revetement gastro-resistant
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
WO2007027566A2 (fr) 2005-09-02 2007-03-08 Genzyme Corporation Recepteurs moleculaires polymeriques utilises comme sequestrants du phosphate
PT1924246E (pt) 2005-09-15 2016-02-10 Genzyme Corp Formulação sachê para polímeros com funcionalidade amina
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
BRPI0717008A2 (pt) * 2006-09-01 2014-01-21 Usv Ltd Processo para o preparo de cloridrato de sevelamer e formulação do mesmo
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
BRPI0720234A2 (pt) 2006-12-14 2013-12-24 Genzyme Corp Composição farmacêutica
KR20110059750A (ko) * 2008-09-02 2011-06-03 유에스브이 리미티드 가교 폴리머
CA2749397A1 (fr) * 2009-01-22 2010-08-05 Usv Limited Compositions pharmaceutiques comprenant un polymere liant le phosphate
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803237A (en) * 1969-11-03 1974-04-09 Upjohn Co Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
ZA804914B (en) * 1979-08-29 1981-08-26 Rohm & Haas The production of powdered resin and the powdered resin so produced
US4439419A (en) * 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4404346A (en) * 1980-08-05 1983-09-13 Rohm And Haas Company Production of powdered resin and the powdered resin so produced
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
AU633491B2 (en) * 1988-06-24 1993-02-04 Pharmacia & Upjohn Company Fine-milled colestipol hydrochloride
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
EP0429541B1 (fr) * 1988-08-26 1993-12-01 The Upjohn Company Chlorhydrate de colestipol en fines perles

Also Published As

Publication number Publication date
CA2110166A1 (fr) 1993-01-21
SK194A3 (en) 1994-11-09
HU9400004D0 (en) 1994-05-30
JP3313710B2 (ja) 2002-08-12
SK281920B6 (sk) 2001-09-11
DK0592594T3 (da) 1999-08-16
FI106843B (fi) 2001-04-30
CZ286958B6 (cs) 2000-08-16
ES2124736T3 (es) 1999-02-16
AU669664B2 (en) 1996-06-20
FI935943A (fi) 1993-12-30
JPH06509097A (ja) 1994-10-13
FI935943A0 (fi) 1993-12-30
US5490987A (en) 1996-02-13
PL169045B1 (pl) 1996-05-31
AU2293392A (en) 1993-02-11
KR100240362B1 (ko) 2000-02-01
HU222242B1 (hu) 2003-05-28
CZ282693A3 (en) 1994-06-15
RU2108090C1 (ru) 1998-04-10
EP0592594A1 (fr) 1994-04-20
NO940008L (no) 1994-01-03
CA2110166C (fr) 2002-11-05
DE69227773D1 (de) 1999-01-14
WO1993000915A1 (fr) 1993-01-21
HUT69394A (en) 1995-09-28
EP0592594B1 (fr) 1998-12-02
NO940008D0 (no) 1994-01-03
DE69227773T2 (de) 1999-05-20
ATE173931T1 (de) 1998-12-15

Similar Documents

Publication Publication Date Title
NO307686B1 (no) Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter
MX9500243A (es) Composicion de liberacion acelerada que contiene bromocriptina.
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
NO942325L (no) Transdermalt administrert system som inneholder acetylsalicylsyre for tromboseterapi og cancerprofylakse
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
CA2456604A1 (fr) Composition pharmaceutique comprenant du lumiracoxib
NO308644B1 (no) Anvendelse av 4-aminopyridin for fremstilling av et farmasøytisk preparat
CA2180178A1 (fr) Utilisation des derives 2,3-diaryl-1-benzopyrane dans la production d'un medicament employe dans le traitement et la prevention de la diminution du volume du tissu osseux et de l'osteoporose
NO933321L (no) NADH og NADPH som legemiddel til behandling av Mobus Alzheimer
Plante et al. Dipyridamole-aspirin versus low doses of heparin in the prophylaxis of deep venous thrombosis in abdominal surgery
ES2087915T3 (es) Agente terapeutico y procedimiento que inhibe la vascularizacion de tumores.
Pitkeathly et al. Indomethacin in in-patient treatment of rheumatoid arthritis.
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
YU56702A (sh) Korišćenje fsh za lečenje neplodnosti
CA2184361C (fr) Formes galeniques solides renfermant du bismuth
GB2174004A (en) Effervescent tablets
EP0681476B1 (fr) Preparation pharmaceutique de doses unitaires de subsalicylate de bismuth
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
US6162792A (en) Use of spiramycin for treating gastrointestinal disorders caused by H. pylori
KR880009652A (ko) 3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물
NO961046L (no) Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyre
SU1351605A1 (ru) Способ лечени склерокистозных ичников
RU2019161C1 (ru) Средство профилактики острых приступов глаукомы при геомагнитных бурях

Legal Events

Date Code Title Description
MK1K Patent expired